𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain

✍ Scribed by Gemma Llort; Carmen Yagüe Muñoz; Mercè Peris Tuser; Ignacio Blanco Guillermo; José Ramón Germà Lluch; Allen E. Bale; Mayra Alvarez Franco

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
167 KB
Volume
19
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis

BRCA1 and BRCA2 mutations underlie a substantial proportion of all hereditary breast cancer. The mutational spectrum in these genes is very broad, with hundreds of different BRCA mutations reported worldwide. However, high frequency founder mutations make up a substantial fraction of all mutations in some ethnic groups. We directly sequenced BRCA1 and BRCA2 in 35 Spanish breast/ovarian cancer families and found 13 mutations of which 3 had been reported previously in Spain. The ten novel mutations are: IVS5+1 G>A, 1491delA, Leu1086Ter, and Gln895Ter in BRCA1; Glu49Ter, 5373delGTAT, 5947delCTCT, 6672delTA, 8281insA, and Pro3039Leu (which also involves a splice site) in BRCA2. Our data, in combination with previous reports, indicate that 14 mutations have been seen recurrently in Spanish families. Analyzing these 14 mutations in 42 previously untested breast/ovarian cancer families revealed only two families testing positive, one for BRCA1 185delAG and one for BRCA2 9254delATCAT. While several mutations have been found recurrently in Spain, none appear to be high frequency founder mutations based on studies of breast and ovarian cancer families.

📜 SIMILAR VOLUMES

Recurrent BRCA1 and BRCA2 germline mutat
Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: A founder mutation of BRCA1 identified in the Chinese population
✍ Ui-Soon Khoo; Kelvin Y.K. Chan; Annie N.Y. Cheung; W.C. Xue; D.H. Shen; K.Y. Fun 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Previous mutational analysis for BRCA gene mutations in sporadic ovarian cancer occurring in Chinese patients in Hong Kong identified six germline BRCA1 mutations and one germline BRCA2 mutation, six of which were novel (Khoo et al., 2000). Knowledge of BRCA gene mutations in the Chinese population

Increased frequency of TP53 mutations in
Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours
✍ Susan J. Ramus; Lynda G. Bobrow; Paul D.P. Pharoah; Damon S. Finnigan; Ami Fishm 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

We screened 81 ovarian tumours (30 BRCA1 associated, 18 BRCA2 associated, and 33 sporadic) for somatic TP53 mutations using both DNA analysis and immunostaining. TP53 mutations were significantly more frequent in tumours with mutations in BRCA1 (70% by immunostaining and 60% by DNA analysis) and BRC

BRCA1 and BRCA2 mutations in Russian fam
BRCA1 and BRCA2 mutations in Russian familial breast cancer
✍ Irina V. Tereschenko; Victoria M. Basham; Bruce A.J. Ponder; Paul D.P. Pharoah 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 24 KB 👁 2 views

We have screened index cases from 25 Russian breast/ovarian cancer families for germ-line mutations in all coding exons of the BRCA1 and BRCA2 genes, using multiplex heteroduplex analysis. In addition we tested 22 patients with breast cancer diagnosed before age 40 without family history and 6 patie

Frequency of BRCA1/BRCA2 mutations in a
Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases
✍ Kathleen E. Malone; Janet R. Daling; Cassandra Neal; Nicola M. Suter; Cecilia O' 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

## BACKGROUND. There is a clear and growing need for data regarding BRCA1 and BRCA2 mutation frequencies among breast carcinoma cases not specifically ascertained on the basis of extreme family history profiles. Toward this end, the authors previously reported results with regard to BRCA1 in breast